Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q3 2024 Earnings Call Transcript November 6, 2024
Teva Pharmaceutical Industries Limited misses on earnings expectations. Reported EPS is $-0.3857 EPS, expectations were $0.66.
Operator: Hello, and welcome to the Q3 2024 Teva Pharmaceuticals Industries Limited Earnings Conference Call. My name is Alex, and I’ll be coordinating the call today. [Operator Instructions] I’ll now hand it over to your host, Ran Meir, Senior Vice President, Head of...
